Publikacje w prasie - Ypsomed

Sébastien Delarive to become new Senior Vice President Diabetes Care.

Ypsomed focuses on growth and strengthens its business units

23-02-2022 - 07:00 Press Releases Ypsomed Group

Burgdorf – With the aim of focusing on changing customer needs, Ypsomed is stepwise optimizing the organisation of the business units and the Management Board.

Tematy:

Access & Expansion

Więcej... Ypsomed focuses on growth and strengthens its business units

Ypsomed is growing and expects a further increase

04-11-2021 - 07:00 Ad hoc announcement pursuant to Art. 53 LR

Burgdorf – Ypsomed (SWX: YPSN) generated a growth in turnover of 11.6% in the first half of 2021/22 compared to the previous year and achieved a consolidated total turnover of CHF 222.6 million. On its continued growth trend, the company achieved an operating result (EBIT) of CHF 10.5 million. This corresponds to an increase of 23.1%. Net profit increased to CHF 7.1 million (previous year: CHF 6.7 million).

Więcej... Ypsomed is growing and expects a further increase

World’s first autoinjector with fully integrated connectivity

12-10-2021 - 07:00 Press Releases Ypsomed Group

Burgdorf – Ypsomed has introduced the world’s first autoinjector for prefilled syringes with integrated connectivity. The YpsoMate On combines the advantages of the proven YpsoMate autoinjector with the options of digital therapy support. The YpsoMate On follows an eco-design principle which allows easy recycling of electronic components and encourages the use of sustainable components.

Tematy:

Innovation & Digital Health

Więcej... World’s first autoinjector with fully integrated connectivity

Continuous therapy management via smartphone

07-09-2021 - 07:00 Press Releases Ypsomed Group

Burgdorf – Ypsomed has expanded the range of features of the mylife YpsoPump insulin pump system. New - the app-based integration of the Dexcom G6 Continuous Glucose Monitoring (CGM) System enables people with diabetes to continuously manage their therapy via their smartphone. Users of the mylife YpsoPump receive the advanced function of the pump system – called “mylife Assist” – via an update to the mylife App. The first countries launching mylife Assist are Germany, Switzerland, Austria and Denmark, with further countries following soon.

Tematy:

Innovation & Digital Health

Więcej... Continuous therapy management via smartphone

Ypsomed expands its options

01-07-2021 - 07:00 Press Releases Ypsomed Group

Burgdorf – The Annual General Meeting of the Ypsomed Group on 30 June 2021 approved all proposals of the Board of Directors. The AGM elected Ms Betül Susamis Unaran as a new member of the Board of Directors and authorised the Board to increase the share capital.

Tematy:

Management

Więcej... Ypsomed expands its options